“The F.D.A. continues to explore the concerns raised recently regarding information provided to the F.D.A. on Zyprexa’s safety,” Dr. Mitchell Mathis, a deputy director in the psychiatry division of the agency’s center for drug evaluation and research, said.
Source: U.S. Wonders if Drug Data Was Accurate - New York Times
No comments:
Post a Comment